Table 3.
Model 1 | Model 2 | Model 3 | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |
TyG index | 0.825 | 0.559–1.216 | 0.331 | 1.398 | 1.197–1.633 | < 0.001 | 1.355 | 1.154–1.591 | < 0.001 |
T1 | Reference | Reference | Reference | ||||||
T2 | 1.268 | 1.025–1.569 | 0.029 | 1.330 | 1.061–1.668 | 0.013 | 1.283 | 1.024–1.607 | 0.031 |
T3 | 1.403 | 1.129–1.745 | 0.002 | 1.578 | 1.249–1.994 | < 0.001 | 1.496 | 1.183–1.893 | < 0.001 |
Model 1: unadjusted
Model 2: adjusted for age and sex
Model 3: adjusted for sex, age, BMI, smoking, drinking, hypertension, eGFR, antiplatelet drug use, antilipidemic drug use, and antihypertensive drug use
TyG triglyceride–glucose, CAD coronary artery disease, OR odds ratio, CI confidence interval, BMI body mass index, eGFR estimated glomerular filtration rate